"It's not like marketing salty snacks"

June 2008
Marketing Health Services;Summer2008, Vol. 28 Issue 2, p17
Academic Journal
The article presents an interview with Ellen Sonet, vice president of marketing at Memorial Sloan-Kettering Cancer Center. Topics she discusses include healthcare marketing compared to other types of consumer marketing, the challenge of discovering the genuine attitudes and needs of patients, and participation with online communities. Also discussed are things which she has learned from the online community with whom she has worked that have surprised her.


Related Articles

  • Memorial Sloan Kettering breaks ground on $271M cancer center in Middletown. Fitzgerald, Beth // njbiz;9/29/2014, Vol. 27 Issue 39, p6 

    The article discusses the second out-patient cancer center of cancer treatment and research institution Memorial Sloan Kettering Cancer Center called MSK Monmouth located in Middletown, New Jersey which aims to provide patients post-operative care nearer to their homes.

  • MSK affiliate buys building in Montvale.  // njbiz;7/20/2015, Vol. 28 Issue 29, p3 

    The article reveals that Memorial Sloan Kettering Cancer Center will develop a 140 million U.S. dollars outpatient cancer center in Montvale, New Jersey.

  • Poorly Differentiated Thyroid Carcinoma Presenting with Gross Extrathyroidal Extension: 1986-2009 Memorial Sloan-Kettering Cancer Center Experience. Ibrahimpasic, Tihana; Ghossein, Ronald; Carlson, Diane L.; Chernichenko, Natalya; Nixon, Iain; Palmer, Frank L.; Lee, Nancy Y.; Shaha, Ashok R.; Patel, Snehal G.; Tuttle, R. Michael; Balm, Alfons J.M.; Shah, Jatin P.; Ganly, Ian // Thyroid;Aug2013, Vol. 23 Issue 8, p997 

    Purpose: To describe the outcome of patients with poorly differentiated thyroid cancer (PDTC) presenting with gross extrathyroidal extension (ETE). Materials and Methods: After obtaining Institutional Review Board approval, we performed a retrospective review of a consecutive series of thyroid...

  • Rockefeller pavilion wins in walk-in.  // Crain's New York Business;11/22/99, Vol. 15 Issue 47, p20 

    Focuses on the success of New York City's Memorial Sloan-Kettering Cancer Center with ambulatory care. Average number of patients per day; Number of outpatient sites being run by the hospital.

  • Memorial has money to make money in bonds. Messina, Judith // Crain's New York Business;8/27/2001, Vol. 17 Issue 35, p19 

    Reports the plan of Memorial Sloan-Kettering (MSK) Cancer Center to sell health care bonds in New York, New York. Assistance on expansion and refinancing debt; Financial strength and salability of the health care bond; Accounts on the expansion plans of the health care facility.

  • Nominations Sought for Paul Marks Prize for Cancer Research.  // Ascribe Newswire: Medicine;2/9/2007, p1 

    The article announces nominations for the Paul Marks Prize for Cancer Research that is open to all researchers who have made significant contributions in increasing the understanding of cancer or improving the treatment of the disease. The said award was established by Memorial Sloan-Kettering...

  • Selected Reviews on Topics in Oncologic Pathology Related to Tumors of the Breast, Gynecologic Organs, and Head and Neck Region. Klimstra, David S.; Soslow, Robert A.; Ghossein, Ronald A.; Brogi, Edi // Archives of Pathology & Laboratory Medicine;May2009, Vol. 133 Issue 5, p681 

    The article offers information on the continuing medical education course, "The Surgical Pathology of Neoplastic Diseases" which is sponsored by Memorial Sloan-Kettering Cancer Center in New York City on May 12-16, 2008. The course highlights the seven review articles that covered the...

  • NEW FRONTIERS for Big Data. Iskowitz, Marc // Medical Marketing & Media;Mar2014, Vol. 49 Issue 3, p28 

    The article discusses the innovative use of big data and analytics to improve medical care outcome. It cites the reasons behind the delay of treatment-advisor tool's or IBM Watson Oncology's use by Memorial Sloan Kettering Cancer Center in New York. It also explains the promise and pitfalls of...

  • 'Financial toxicity' looms as cancer combinations proliferate. Morrison, Chris // Nature Biotechnology;Aug2015, Vol. 33 Issue 8, p783 

    The article focuses on the Conceptual Framework unveiled by the American Society of Clinical Oncology (ASCO) to evaluate the cost and value of new cancer treatment options. The DrugAbacus launched by New York's Memorial Sloan Kettering Cancer Center which allows users to calculate the value of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics